设为首页 加入收藏

TOP

Marqibo(十二)
2013-10-25 11:30:37 来源: 作者: 【 】 浏览:9967次 评论:0
sulfate injection, solution
Product Information
Item Code (Source) NDC:20536-323    
Route of Administration INTRAVENOUS DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Vincristine Sulfate (Vincristine) Vincristine Sulfate 5 mg  in 5 mL
Inactive Ingredients
Ingredient Name Strength
Mannitol 500 mg  in 5 mL
Sodium Hydroxide  
Sulfuric Acid  
Water  
Packaging
Item Code Package Description
1 NDC:20536-323-01 5 mL in 1 VIAL, GLASS
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA202497 01/14/2013 
Part 2 of 3
SPHINGOMYELIN-CHOLESTEROL
cholesterol, citric acid monohydrate, sodium citrate, alcohol, and water injection, suspension, liposomal
Product Information
Item Code (Source) NDC:20536-324    
Route of Administration INTRAVENOUS DEA Schedule     
Inactive Ingredients
Ingredient Name Strength
Cholesterol  
Citric Acid Monohydrate  
Sodium Citrate  
Alcohol  
Water  
Packaging
Item Code Package Description
1 NDC:20536-324-01 1 mL in 1 VIAL, GLASS
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA202497 01/14/2013 
Part 3 of 3
SODIUM PHOSPHATE
sodium phosphate, dibasic, heptahydrate, sodium chloride, and water injection, solution
Product Information
Item Code (Source) NDC:20536-325    
Route of Administration INTRAVENOUS DEA Schedule     
Inactive Ingredients
Ingredient Name Strength
Sodium Phosphate, Dibasic, Heptahydrate 14.2 mg  in 1 mL
Sodium Chloride  
Water  
Packaging
Item Code Package Description
1 NDC:20536-325-01 25 mL in 1 VIAL, GLASS
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA202497 01/14/2013 
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA202497 01/14/2013 
Labeler - Talon Therapeutics, Inc (147517044)
Establishment
Name Address ID/FEI Operations
Fine Chemicals (PTY)  568855923 API MANUFACTURE(20536-322), ANALYSIS(20536-322)
Establishment
Name Address ID/FEI Operations
Hospira Australia Pty Ltd  758967652 MANUFACTURE(20536-322), ANALYSIS(20536-322)
Establishment
Name Address ID/FEI Operations
Cangene  244844056 MANUFACTURE(20536-322), ANALYSIS(20536-322)
Establishment
Name Address ID/FEI Operations
Jubilant Hollister-Stier  069263643 MANUFACTURE(20536-322), ANALYSIS(20536-322)
Establishment
Name Address ID/FEI Operations
Nucro  241266845 ANALYSIS(20536-322)
Establishment
Name Address ID/FEI Operations
PPD Development, LP  838082055 ANALYSIS(20536-322)
Establishment
Name Address ID/FEI Operations
AndersonBrecon  053217022 LABEL(20536-322), PACK(20536-322)
R
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 9 10 11 12 13 下一页 尾页 12/13/13
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇ICLUSIG(PONATINIB HYDROCHLORIDE.. 下一篇MARQIBO (Vincristine sulfate li..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位